Zhi-Hong Yang1, Milton Pryor1, Audrey Noguchi2, Maureen Sampson3, Brittany Johnson1, Matthew Pryor1, Kwame Donkor1, Marcelo Amar1, Alan T Remaley1. 1. Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, 20892, USA. 2. Murine Phenotyping Core, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA. 3. Clinical Center, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, 20892, USA.
Abstract
SCOPE: Palmitoleic acid (palmitoleate; C16:1 n-7), an omega-7 monounsaturated fatty acid (MUFA) found in plants and marine sources, has been shown to favorably modulate lipid and glucose metabolism. However, its impact on atherosclerosis has not been examined in detail. METHODS AND RESULTS: LDL receptor knock out (LDLR-KO) mice are fed a Western diet supplemented with 5% (w/w) palmitoleate concentrate, oleic-rich olive oil, or none (control) for 12 weeks. Dietary palmitoleate increases hepatic C16:1 levels, improves plasma and hepatic lipid/lipoprotein profiles (≈40% decrease in triglycerides), and reduces the atherosclerotic plaque area by ≈45% compared with control or olive oil group (p < 0.05). These favorable changes are accompanied by the downregulation of key genes, such as Srebp1c, Scd1, Il-1β, and Tnfα. ApoB-depleted plasma from mice fed palmitoleate has increased cholesterol efflux capacity by 20% from ABCA1-expressing cells (p < 0.05). A beneficial effect of palmitoleate on glucose metabolism (54% decreased in HOMA-IR, p < 0.05) is also observed. CONCLUSIONS: Dietary-supplemented palmitoleate reduces atherosclerosis development in LDLR-KO mice, and is associated with improvement of lipid and glucose metabolism and favorable changes in regulatory genes involved in lipogenesis and inflammation. These findings imply the potential role of dietary palmitoleate in the prevention of cardiovascular disease and diet-induced metabolic disorders.
SCOPE: Palmitoleic acid (palmitoleate; C16:1 n-7), an omega-7 monounsaturated fatty acid (MUFA) found in plants and marine sources, has been shown to favorably modulate lipid and glucose metabolism. However, its impact on atherosclerosis has not been examined in detail. METHODS AND RESULTS:LDL receptor knock out (LDLR-KO) mice are fed a Western diet supplemented with 5% (w/w) palmitoleate concentrate, oleic-rich olive oil, or none (control) for 12 weeks. Dietary palmitoleate increases hepatic C16:1 levels, improves plasma and hepatic lipid/lipoprotein profiles (≈40% decrease in triglycerides), and reduces the atherosclerotic plaque area by ≈45% compared with control or olive oil group (p < 0.05). These favorable changes are accompanied by the downregulation of key genes, such as Srebp1c, Scd1, Il-1β, and Tnfα. ApoB-depleted plasma from mice fed palmitoleate has increased cholesterol efflux capacity by 20% from ABCA1-expressing cells (p < 0.05). A beneficial effect of palmitoleate on glucose metabolism (54% decreased in HOMA-IR, p < 0.05) is also observed. CONCLUSIONS: Dietary-supplemented palmitoleate reduces atherosclerosis development in LDLR-KO mice, and is associated with improvement of lipid and glucose metabolism and favorable changes in regulatory genes involved in lipogenesis and inflammation. These findings imply the potential role of dietary palmitoleate in the prevention of cardiovascular disease and diet-induced metabolic disorders.
Authors: Camila O de Souza; Alexandre A S Teixeira; Luana A Biondo; Edson A Lima Junior; Helena A P Batatinha; Jose C Rosa Neto Journal: J Cell Physiol Date: 2017-03-24 Impact factor: 6.384
Authors: H Shimano; N Yahagi; M Amemiya-Kudo; A H Hasty; J Osuga; Y Tamura; F Shionoiri; Y Iizuka; K Ohashi; K Harada; T Gotoda; S Ishibashi; N Yamada Journal: J Biol Chem Date: 1999-12-10 Impact factor: 5.157
Authors: Jon H Miyake; Xuandao T Duong-Polk; John M Taylor; Emma Z Du; Lawrence W Castellani; Aldons J Lusis; Roger A Davis Journal: Arterioscler Thromb Vasc Biol Date: 2002-01 Impact factor: 8.311
Authors: Neil K Huang; Nirupa R Matthan; Jean M Galluccio; Peilin Shi; Alice H Lichtenstein; Dariush Mozaffarian Journal: J Nutr Date: 2020-06-01 Impact factor: 4.798
Authors: Miguel A Bermúdez; Laura Pereira; Cristina Fraile; Laura Valerio; María A Balboa; Jesús Balsinde Journal: Cells Date: 2022-07-08 Impact factor: 7.666
Authors: Denisa Miklankova; Irena Markova; Martina Hüttl; Barbora Stankova; Hana Malinska Journal: J Diabetes Res Date: 2022-09-13 Impact factor: 4.061
Authors: Rudolf Poledne; Hana Malinska; Hana Kubatova; Jiri Fronek; Filip Thieme; Sona Kauerova; Ivana Kralova Lesna Journal: Nutrients Date: 2019-12-18 Impact factor: 5.717